# DESCRIPTION

- claim priority to provisional application

## FIELD OF THE INVENTION

- introduce corneal endothelial cells generation

## BACKGROUND

- describe corneal endothelium structure and function

## SUMMARY

- summarize generation of clinical-grade corneal endothelial cells
- describe method of producing corneal endothelial cells
- detail culturing of iPSCs and hESCs
- identify differentiating cells by neural crest markers
- identify matured CECs by markers
- describe method of preventing or treating corneal associated diseases
- detail reprogramming method for producing iPSCs
- select and expand iPSC colonies
- confirm iPSCs and hESCs by gene expression
- describe method for stem cell therapy
- describe method for evaluating physiological function or toxicity
- describe composition of cryopreserved corneal endothelial cells

## DETAILED DESCRIPTION

- introduce conical endothelial cells (CECs) from human embryonic stem cells (hESCs) and peripheral blood mononuclear cell (PB
- describe morphology of differentiating hESCs and iPSCs
- investigate expression of pluripotent and corneal endothelium (CE)-associated markers
- define human embryonic stem cells (hESCs)
- motivate pluripotent stem cells in regenerative medicine
- describe human induced pluripotent stem cells (iPSCs)
- outline method of producing corneal endothelial cells (CECs)
- specify reprogramming or pluripotent factors
- describe culturing cells with differentiation factors
- specify gelatinous protein coating
- describe media composition
- introduce corneal endothelium
- describe importance of corneal endothelial cells (CECs)
- outline corneal diseases and associated disorders
- describe Fuchs endothelial corneal dystrophy (FECD)
- outline symptoms of Fuchs endothelial corneal dystrophy (FECD)
- describe keratoconus
- describe iridocorneal endothelial syndrome (ICE)
- describe bullous keratopathy
- outline methods of treatment
- describe kits

### EXAMPLES

- introduce derivation of clinical-grade corneal endothelial cells
- describe materials and methods for subject selection
- outline isolation and cryopreservation of peripheral blood mononuclear cells
- describe culture of human embryonic stem cells
- detail generation of induced pluripotent stem cells
- characterize induced pluripotent stem cells by flow cytometry
- characterize induced pluripotent stem cells by quantitative real-time PCR
- describe differentiation of induced pluripotent stem cells into corneal endothelial cells
- characterize corneal endothelial cells by quantitative real-time PCR
- characterize corneal endothelial cells by immunocytochemistry
- describe cryopreservation of corneal endothelial cells
- perform RNA-Seq analysis of non-cryopreserved and cryopreserved corneal endothelial cells
- describe injection of cryopreserved corneal endothelial cells into rabbits
- outline post-injection care of rabbits
- describe rabbit injection model
- describe clinical evaluation of rabbit eyes
- describe histological evaluation of rabbit eyes
- describe monkey injection model
- describe clinical evaluation of monkey eyes
- describe histological evaluation of monkey eyes
- describe necropsy and CBC/blood chemistry examination
- generate and validate human induced pluripotent stem cells (iPSCs)
- differentiate human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into corneal endothelial
- analyze gene expression and immunocytochemistry of differentiating corneal endothelial cells (CECs)
- validate cryopreserved human embryonic stem cells (hESC)- and induced pluripotent stem cells (iPSC)-derived corneal endoth
- discuss derivation of clinical-grade corneal endothelial cell (CEC)-like cells
- discuss effects of cryopreservation on hESC- and iPSC-derived CECs
- discuss safety concerns and novelty of the study

## EQUIVALENTS

- acknowledge equivalents

